Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
1.000
-0.070 (-6.53%)
Apr 29, 2026, 11:00 AM EDT - Market open
Arcadia Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2 | 3 | 8 | 3 | 7 | 23 | |
| Market Cap Growth | -53.25% | -66.35% | 132.51% | -47.96% | -71.05% | -32.20% | |
| Enterprise Value | -2 | -3 | 2 | -11 | -14 | -8 | |
| Last Close Price | 1.07 | 1.98 | 5.92 | 3.13 | 10.84 | 41.60 | |
| PS Ratio | 0.45 | 0.56 | 1.60 | 0.78 | 1.34 | 3.40 | |
| PB Ratio | 0.35 | 0.66 | 1.30 | 0.27 | 0.32 | 0.74 | |
| P/TBV Ratio | 0.53 | 0.66 | 1.31 | 0.27 | 0.32 | 0.75 | |
| EV/Sales Ratio | - | - | 0.34 | - | - | - | |
| Debt / Equity Ratio | - | - | 0.03 | 0.08 | 0.10 | 0.11 | |
| Net Debt / Equity Ratio | -1.10 | -1.10 | -0.66 | -0.84 | -0.89 | -0.81 | |
| Net Debt / EBITDA Ratio | 0.87 | 0.87 | 0.56 | 1.91 | 2.76 | 1.09 | |
| Net Debt / FCF Ratio | 0.96 | 0.96 | 0.42 | 0.70 | 1.33 | 0.95 | |
| Asset Turnover | 0.48 | 0.48 | 0.30 | 0.18 | 0.14 | 0.15 | |
| Inventory Turnover | 2.94 | 2.94 | 3.29 | 2.00 | 1.06 | 2.18 | |
| Quick Ratio | 2.42 | 2.42 | 2.11 | 3.38 | 5.20 | 5.96 | |
| Current Ratio | 3.09 | 3.09 | 3.61 | 4.17 | 6.03 | 7.02 | |
| Return on Equity (ROE) | -45.14% | -45.14% | -45.62% | -31.72% | -14.62% | -54.01% | |
| Return on Assets (ROA) | -32.71% | -32.71% | -28.06% | -15.04% | -12.38% | -33.30% | |
| Return on Capital Employed (ROCE) | -117.00% | -117.00% | -68.10% | -36.30% | -29.20% | -62.50% | |
| Earnings Yield | -107.28% | -86.03% | -87.10% | -402.29% | -230.24% | -63.54% | |
| FCF Yield | -217.36% | -174.31% | -119.34% | -440.21% | -210.37% | -116.48% | |
| Buyback Yield / Dilution | -0.35% | -0.35% | -10.22% | -106.37% | -12.66% | -113.68% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.